U029 GI Skin: Cutaneous Manifestations of Gastrointestinal Inflammatory Disorders
DESCRIPTION
This session focuses on the presentation, diagnosis, and multi-disciplinary management of cutaneous manifestations of gastrointestinal inflammatory conditions. Inflammatory bowel disease impacts the skin with specific, reactive, and associated conditions. In addition, other inflammatory conditions may impact both the skin and GI tract including dermatoses associated with stomas. This session is geared toward general dermatologists who are evaluating and managing these patients in conjunction with the gastroenterology team and collaborating on their care.
LEARNING OBJECTIVES
Recognize and diagnose cutaneous manifestations of inflammatory gastrointestinal conditions
Evaluate patients with cutaneous manifestations of inflammatory gastrointestinal conditions and recognize when and how to initiate an evaluation for gastrointestinal disease based on the cutaneous presentation.
Collaborate with multi disciplinary providers to treat patients' cutaneous manifestations in the context of their gastrointestinal condition and treatment plan.
SCHEDULE
7:30 AM
Introduction
Afsaneh Alavi, MD, FAAD, Alexandra Coromilas, MD, FAAD
7:32 AM
Cutaneous Crohn Disease
Alexandra Coromilas, MD, FAAD
7:42 AM
HS and Perianal Crohn Disease
Mika Takaichi, MD, PhD
7:52 AM
Neutrophilic Dermatoses in IBD
Bridget Shields, MD, FAAD
8:02 AM
Stoma Skin: What Every Dermatologist Should Recognize
Anagha Bangalore Kumar, MD, MBBS, FAAD
8:12 AM
Treatment-Associated Skin Disease in IBD
Alexandra P. Charrow, MD, FAAD
8:22 AM
Discussion
DIRECTOR
Afsaneh Alavi, MD, FAAD
CO-DIRECTOR
Alexandra Coromilas, MD, FAAD
SPEAKERS
Anagha Bangalore Kumar, MD, MBBS, FAAD
Alexandra P. Charrow, MD, FAAD
Bridget Shields, MD, FAAD
Mika Takaichi, MD, PhD
Department of Dermatology Graduate School of Medicine, Osaka Metropolitan University Osaka, Japan
DISCLOSURES
Afsaneh Alavi, MD, FAAD
AbbVie – Advisory Board(Honoraria); Almirall – Data Safety Monitoring Board(Fees); Alumis – Advisory Board(Honoraria); Avalo – Consultant (1099 relationship)(Fees); Blueprint Medicines – Advisory Board(Honoraria); Cantargia – Consultant (1099 relationship)(Fees); Dermatology Times (MMM MultiMedia Medical, LLC) – Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); InflaRx – Data Safety Monitoring Board(Honoraria); Leo Foundation – Advisory Board(Honoraria); MoonLake Immunotherapeutics – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Oruka – Data Safety Monitoring Board(Honoraria); Sanofi – Advisory Board(Honoraria); Shattuck Labs – Data Safety Monitoring Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Zura Bio – Data Safety Monitoring Board(Honoraria);
Anagha Bangalore Kumar, MD, MBBS, FAAD
No financial relationships exist with ineligible companies.
Alexandra P. Charrow, MD, FAAD
Avalo – Consultant (1099 relationship)(Fees); Dermatology Foundation – Investigator(Grants/Research Funding); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Fees), Investigator(No Compensation Received); Insmed – Investigator(No Compensation Received); Insmed Incorporated – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(No Compensation Received); Sonoma Biotherapeutics – Investigator(No Compensation Received); UCB Pharma – Advisory Board(Honoraria); Wedbush Securities – Consultant (1099 relationship)(Honoraria);
Alexandra Coromilas, MD, FAAD
No financial relationships exist with ineligible companies.
Bridget Shields, MD, FAAD
Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria); UpToDate, Inc – Other(Honoraria);
Mika Takaichi, MD, PhD
No financial relationships exist with ineligible companies.